Hanoi (VNS/VNA) - The IVACFLU-Svaccines, which have been produced in Việt Nam to protect against seasonal flusuch as A/H1N1, A/H3N2, and B, are now available on the market, the Instituteof Vaccines and Medical Biologicals under the Ministry of Health has said.
As many as 50,000 doses of vaccines have been produced for the first time atthe cost of between 120,000-180,000 VND (5.2-7.8 USD) per dose, half the costof imported vaccines.
The influenza vaccines have been studied and produced based on embryonicegg production technology in 2010 under co-operation between the institute andthe Program for Appropriate Technology in Health (PATH).
The institute had undergone multiple phases of clinical trials from 2017onward. It has proved to be safe and capable of strengthening adults’ immunesystems.
On January 14, the vaccines were licensed by the Ministry of Health to protectagainst seasonal flu including H1N1, H3N2 and B.
The institute is capable of manufacturing 1.5 million doses of vaccines peryear.
Dr Duong Huu Thai, Director of the institute, said the vaccines have been shownas safe to improve the immune systems of people aged between 18 and 60.
Vaccines will be available in Hai Phong, KhanhHoa, Long An, and Dong Nai provinces before being supplied to other localities.
The IVACFLU-S vaccines are contraindicated for people with a history ofhypersensitivity to the ingredients in the vaccine or allergic to proteins inchicken eggs and chicken.
Seasonal flu is a respiratory disease that can lead to fatalities. As many as650,000 deaths and about 3-5 million serious cases are recorded due to seasonalflu around the world each year.-VNS/VNA